BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 11246303)

  • 1. Tissue factor pathway inhibitor response does not correlate with tissue factor-induced disseminated intravascular coagulation and multiple organ dysfunction syndrome in trauma patients.
    Gando S; Nanzaki S; Morimoto Y; Ishitani T; Kemmotsu O
    Crit Care Med; 2001 Feb; 29(2):262-6. PubMed ID: 11246303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis.
    Gando S; Kameue T; Morimoto Y; Matsuda N; Hayakawa M; Kemmotsu O
    Crit Care Med; 2002 Aug; 30(8):1729-34. PubMed ID: 12163784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients.
    Gando S; Kameue T; Matsuda N; Hayakawa M; Morimoto Y; Ishitani T; Kemmotsu O
    Thromb Res; 2003 Jan; 109(2-3):119-24. PubMed ID: 12706640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma: application of clinical decision analysis.
    Gando S; Nanzaki S; Kemmotsu O
    Ann Surg; 1999 Jan; 229(1):121-7. PubMed ID: 9923809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic activation of tissue-factor dependent coagulation pathway in evolving acute respiratory distress syndrome in patients with trauma and sepsis.
    Gando S; Nanzaki S; Morimoto Y; Kobayashi S; Kemmotsu O
    J Trauma; 1999 Oct; 47(4):719-23. PubMed ID: 10528607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined activation of coagulation and inflammation has an important role in multiple organ dysfunction and poor outcome after severe trauma.
    Gando S; Kameue T; Matsuda N; Hayakawa M; Ishitani T; Morimoto Y; Kemmotsu O
    Thromb Haemost; 2002 Dec; 88(6):943-9. PubMed ID: 12529743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble thrombomodulin increases in patients with disseminated intravascular coagulation and in those with multiple organ dysfunction syndrome after trauma: role of neutrophil elastase.
    Gando S; Nakanishi Y; Kameue T; Nanzaki S
    J Trauma; 1995 Oct; 39(4):660-4. PubMed ID: 7473950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation.
    Gando S; Kameue T; Matsuda N; Hayakawa M; Hoshino H; Kato H
    Thromb Res; 2005; 116(2):91-100. PubMed ID: 15907522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome.
    Gando S; Kameue T; Nanzaki S; Hayakawa T; Nakanishi Y
    Crit Care Med; 1997 Nov; 25(11):1820-6. PubMed ID: 9366764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High macrophage migration inhibitory factor levels in disseminated intravascular coagulation patients with systemic inflammation.
    Gando S; Sawamura A; Hayakawa M; Hoshino H; Kubota N; Nishihira J
    Inflammation; 2007 Aug; 30(3-4):118-24. PubMed ID: 17534704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome.
    Gando S; Nakanishi Y; Tedo I
    Crit Care Med; 1995 Nov; 23(11):1835-42. PubMed ID: 7587259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome.
    Gando S; Kameue T; Nanzaki S; Nakanishi Y
    Thromb Haemost; 1996 Feb; 75(2):224-8. PubMed ID: 8815564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.
    Mosad E; Elsayh KI; Eltayeb AA
    Clin Appl Thromb Hemost; 2011 Feb; 17(1):80-7. PubMed ID: 19689998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
    Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
    Am J Hematol; 1996 Jul; 52(3):165-70. PubMed ID: 8756081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseases.
    Asakura H; Ontachi Y; Mizutani T; Kato M; Saito M; Morishita E; Yamazaki M; Suga Y; Takami A; Miyamoto K; Nakao S
    Blood Coagul Fibrinolysis; 2001 Jan; 12(1):1-8. PubMed ID: 11229821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma.
    Kushimoto S; Gando S; Saitoh D; Ogura H; Mayumi T; Koseki K; Ikeda T; Ishikura H; Iba T; Ueyama M; Eguchi Y; Otomo Y; Okamoto K; Endo S; Shimazaki S;
    Thromb Haemost; 2008 Dec; 100(6):1099-105. PubMed ID: 19132236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma tissue factor pathway inhibitor in disseminated intravascular coagulation: comparison of its behavior with plasma tissue factor.
    Takahashi H; Sato N; Shibata A
    Thromb Res; 1995 Nov; 80(4):339-48. PubMed ID: 8585047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRS-associated coagulopathy and organ dysfunction in critically ill patients with thrombocytopenia.
    Ogura H; Gando S; Iba T; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Murata A; Ikeda T; Ishikura H; Ueyama M; Kushimoto S; Saitoh D; Endo S; Shimazaki S;
    Shock; 2007 Oct; 28(4):411-7. PubMed ID: 17577138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
    Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
    Am J Hematol; 1997 Aug; 55(4):169-74. PubMed ID: 9257875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.